Previous close | 2.0890 |
Open | 1.9855 |
Bid | 1.8215 x 0 |
Ask | 1.8600 x 0 |
Day's range | 1.9855 - 1.9855 |
52-week range | 1.3700 - 9.8100 |
Volume | |
Avg. volume | 22 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significantly high institutional ownership implies Emergent BioSolutions' stock price is sensitive to...
Net Loss Narrows in Q4; Full Year Revenues Hit Guidance Mid-Point
Emergent (EBS) reports mixed earnings for fourth-quarter 2023. The company signs a forbearance agreement with its lenders, effective till April 2023-end.